Blood testing

Ended Definitive Contract Awarded Last action

Contract number
W91YTZ21C0006
Awardee
Awarding agency
Obligated
$3,948,537

Award facts

Opportunity
Contract value 100% obligated
$3,948,537.18 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Fort Benning, GA 31905, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00017 · KMW FY25 deob blood testing mahc -$99,999
Funding Only Action P00016 · KMW FY25 decrease moore -$349,999
Funding Only Action P00015 · KMW bmod FY24 deob moore -$286,153
Funding Only Action P00014 · KMW umod funding blood testing moore $1,340,232
Exercise an Option P00013 · FY25 OPT MOD $0
Funding Only Action P00012 · MOD deob FY -$674,548
Funding Only Action P00011 · Whole blood test panel $1,307,591
Funding Only Action P00010 · MOD deob FY23 -$100,000
Exercise an Option P00008 · MOD OPT FY24 $0
Funding Only Action P00007 · MOD fund FY22 realignment $0
Funding Only Action P00006 · MOD fund FY23 $1,275,663
Exercise an Option P00005 · FY23 MOD OPT $0
Funding Only Action P00004 -$661,092
Funding Only Action P00003 · MOD deob -$250,000
Funding Only Action P00002 · MOD fund blood testing $1,238,507
Exercise an Option P00001 · FY22 option $0
Original award $1,208,336
Show all 17

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded Qualtex Laboratories a $3.95 million definitive contract on April 1, 2021, for blood donor laboratory testing services supporting the Department of the Army Medical Command. Qualtex will perform whole blood testing, cytomegalovirus testing, low titer whole blood and plasma testing, and reference laboratory testing at its facility in Fort Moore, Georgia. The contract requires FDA licensure and compliance with all FDA testing requirements, with anticipated annual processing of approximately 14,000 units of whole blood and 1,000 units of platelet or plasma apheresis products. This firm fixed-price contract, with an ultimate completion date of September 30, 2025, includes a base period running through September 2021 and four one-year option periods extending through the contract's conclusion.

Qualtex Laboratories, a subsidiary of Biobridge Global, a nonprofit organization specializing in blood and tissue products, was selected through open competition with no set-aside designation. The company brings established capabilities in transfusion medicine and donor testing, supported by its parent organization's existing contracts with the Department of Veterans Affairs and Department of Defense. Biobridge Global operates multiple subsidiaries including South Texas Blood & Tissue Center, positioning the parent company and Qualtex to deliver comprehensive laboratory services to military medical facilities domestically and internationally.

Quick answers

Who was awarded contract W91YTZ21C0006?

W91YTZ21C0006 was awarded to Qualtex Laboratories by Medical Command (Department of the Army) on April 1, 2021.

How much is contract W91YTZ21C0006 worth?

The government has obligated $3,948,537 on W91YTZ21C0006.

Which agency awarded contract W91YTZ21C0006?

Medical Command (Department of the Army) awarded W91YTZ21C0006, with funding from Defense Health Agency (Department of Defense).

Was contract W91YTZ21C0006 competed?

The extent of competition for W91YTZ21C0006 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login